Assad’s biological weapons absent from US-Russia deal

A military strike once contingent on chemical weapons has now become a game of semantics as a loophole has been exploited:

Syrian President Bashar Assad has two biological weapons bases, developing anthrax and other devastating biological agents, and yet the US-Russia deal aimed at stripping his regime of chemical weapons makes no provisions for his biological weapons capability, Israeli TV reported Sunday night.

There is “not a word” about biological weapons in the agreement that US Secretary of State John Kerry discussed with Israel’s Prime Minister Benjamin Netanyahu in Jerusalem on Sunday, Channel 10 news said.

Assad has two biological weapons bases, one of them subterranean and a second in a coastal location, producing anthrax and other agents, the report said.

Chemical warfare looms over Syria. Israel passes atropine to rebels

Every day, Damascus inches a little closer to fulfilling Isaiah 17:1.

As the Syrian civil way went into its third year this week, signs abounded of increasing readiness for the use of chemical weapons on both sides of the conflict.

Since February, the US, Israel, Ankara and Amman have been aware of Bashar Assad’s resolve to override their threats and resort to deadly poison gas if the rebels closed in on the heart of Damascus. On April 3, an unnamed Syrian army officer made the warning clear. By continuing to advancie on Damascus, he said, “the rebels and their leaders” were assured of “certain death.”

At about the same time, debkafile reported exclusively that the Syrian ruler had ordered protective suits for chemical warfare and gas masks distributed to the 4th and 3rd Divisions defending the capital. Tank commanders were told to activate their filtering systems against chemical and biological agents.